In the next 5 years, the market is expected to grow to $105 billion, representing a 17.5x increase in market value: By 2030, the US GLP-1 patient pool will include 15 million people, representing 9% of Americans with diet-related diseases
Compounded GLP-1 medications are not a substitute for prescribed medical treatment for any condition
[4] [5] These medications mimic the action of naturally occurring incretin hormones, particularly glucagon-like peptide-1 (GLP-1)
iHerb has created an entire GLP-1 Support category featuring nearly 4,700 products
Therefore, you should only consider compounded tirzepatide/pyridoxine from licensed compounding pharmacies when prescribed by a qualified healthcare provider
En el organismo, la carnitina desempea un papel menor en el metabolismo de los hidratos de carbono